美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

0.0058

0.0000

成交量：- -

成交额：- -

市值：5.73万

市盈率：0.02

高：0.0058

开：0.0058

低：0.0058

收：0.0058

52周最高：0.0058

52周最低：0.0058

股本：987.80万

流通股本：- -

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):0.3636

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

交易所：

NYSE

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.calidibio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Calidi Biotherapeutics, Inc.成立时是特拉华州的一家临床阶段免疫肿瘤公司，该公司是一家临床阶段的免疫肿瘤学公司，正在开发基于同种异体干细胞的专有平台，以增强和递送溶瘤病毒以及可能的分子给癌症患者。该公司目前正在开发两个基于干细胞的专有平台和一个包膜牛痘病毒平台，旨在保护溶瘤病毒，无论是天然的还是工程的，不被患者的免疫防御所中和，从而允许肿瘤细胞受到更大的感染，并导致溶瘤病毒的抗肿瘤活性比传统的“裸”溶瘤病毒疗法有潜在的改善。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CLDI.WS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CLDI.WS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI.WS\",,,,,undefined,":{"symbol":"CLDI.WS","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)","latestPrice":0.0058,"timestamp":1771880400000,"preClose":0.0058,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":9878020,"eps":0.36356,"marketStatus":"停牌","change":0,"latestTime":"02-23 16:00:00 EST","open":0.0058,"high":0.0058,"low":0.0058,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.36356,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1771923600000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":0.0058,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI.WS\",,,,,undefined,":{"symbol":"CLDI.WS","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":9878020,"dividePrice":0,"high":0.0058,"amplitude":0,"preClose":0.0058,"low":0.0058,"week52Low":0.0058,"pbRate":"--","week52High":0.0058,"institutionHeld":0,"latestPrice":0.0058,"eps":0.36356,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.36356,"open":0.0058,"prevYearClose":0.0058,"prevWeekClose":0.0058,"prevMonthClose":0.0058,"prevQuarterClose":0.0058,"fiveDayClose":0.0058,"twentyDayClose":0.0058,"sixtyDayClose":0.0058},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLDI.WS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLDI.WS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLDI.WS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.calidibio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Calidi Biotherapeutics, Inc.成立时是特拉华州的一家临床阶段免疫肿瘤公司，该公司是一家临床阶段的免疫肿瘤学公司，正在开发基于同种异体干细胞的专有平台，以增强和递送溶瘤病毒以及可能的分子给癌症患者。该公司目前正在开发两个基于干细胞的专有平台和一个包膜牛痘病毒平台，旨在保护溶瘤病毒，无论是天然的还是工程的，不被患者的免疫防御所中和，从而允许肿瘤细胞受到更大的感染，并导致溶瘤病毒的抗肿瘤活性比传统的“裸”溶瘤病毒疗法有潜在的改善。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.141864},{"month":2,"riseRate":0.5,"avgChangeRate":0.375366},{"month":3,"riseRate":0,"avgChangeRate":-0.288504},{"month":4,"riseRate":0.666667,"avgChangeRate":0.298619},{"month":5,"riseRate":0,"avgChangeRate":-0.076923},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.085582},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.132847},{"month":8,"riseRate":0.333333,"avgChangeRate":0.085174},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.196177},{"month":10,"riseRate":0,"avgChangeRate":-0.457774},{"month":11,"riseRate":0.5,"avgChangeRate":-0.207855},{"month":12,"riseRate":0.666667,"avgChangeRate":0.701396}],"exchange":"NYSE","name":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)","nameEN":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CLDI.WS\",market:\"US\",,,undefined,":null}}